# Invivoscribe, Inc.

Canonical: https://abierto.us/vendors/invivoscribe-inc-r1evmk8mezs9

- UEI: R1EVMK8MEZS9
- CAGE: 455H0
- Location: San Diego, CA
- Awards in window: 2 (3 transactions), $114,292 obligated, March 4, 2026 to July 13, 2026

## Awarding agencies

- National Institutes of Health: 2 awards, $114,292

## Industries

- 325413 In-Vitro Diagnostic Substance Manufacturing: $57,435
- 541990 All Other Professional, Scientific, and Technical Services: $56,857

## Competition

- Not Competed: 1 awards
- Competed Under SAP: 1 awards

## Solicitations won

- NOI for InvivoScribe IGH+IGK Clonality Mega-ABI Assays (75N91026Q00007). https://abierto.us/opportunities/75n91026q00007

## Largest awards

- 75N91026P00014 (purchase order): $57,435, NIH NCI. Purchase of Invivoscribe Igh +igk B-Cell Clonality Assays. https://www.usaspending.gov/award/CONT_AWD_75N91026P00014_7529_-NONE-_-NONE-/
- 75N98026P00913 (purchase order): $56,857, National Institutes of Health Olao. Nci: 1. Igh+igk Clonality Mega-Abi. https://www.usaspending.gov/award/CONT_AWD_75N98026P00913_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/invivoscribe-inc-r1evmk8mezs9.